CD109调控炎症反应并为类风湿关节炎发病所必需
该研究探讨CD109在类风湿关节炎(RA)成纤维样滑膜细胞(FLS)中的作用及其作为治疗靶点的潜力。研究发现CD109在RA患者和CIA小鼠滑膜组织中高表达,沉默CD109或抗CD109抗体治疗可减少促炎因子产生及FLS的迁移、侵袭等有害炎症反应;CD109缺陷小鼠在CIA模型中受保护,抗CD109治疗可预防CIA发病并减轻严重程度。结论提示抑制CD109可能成为RA的新型治疗策略。
要点
- CD109在RA患者和CIA小鼠滑膜组织中高表达,且受IL-1β和TNF-α上调。
- 沉默CD109或抗CD109治疗可减少RA FLS促炎因子产生及迁移、侵袭等反应。
- CD109缺陷小鼠受CIA保护,抗CD109可预防并减轻CIA病变。
核心结论
- CD109具有抗关节炎作用,抑制CD109可能成为RA有前景的新型治疗策略。
研究设计与样本
- 检测RA患者和CIA小鼠滑膜组织及FLS中CD109表达,并构建CD109缺陷小鼠评估CIA严重程度。
- 使用小干扰RNA和抗CD109中和抗体在RA FLS和CIA中进行功能或治疗研究。
主要发现
- CD109在RA患者和CIA小鼠滑膜组织中丰富表达,RA FLS中CD109表达受IL-1β和TNF-α等炎症刺激上调。
- 沉默CD109或抗CD109治疗减少促炎因子产生、细胞迁移、侵袭、趋化潜力和破骨细胞分化,从而减轻RA FLS体外有害炎症反应。
- CD109缺陷小鼠在CIA模型中受保护,抗CD109治疗预防CIA病变发生并改善其严重程度。
临床怎么用
- CD109抑制可能作为RA的新型治疗策略,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the role of CD109 in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) and to evaluate its potential as a therapeutic target. METHODS: CD109 expression was examined in synovial tissues and FLSs from RA patients and collagen-induced arthritis (CIA) model mice. CD109-deficient mice were developed to evaluate the severity of CIA. Small interfering RNAs and a neutralising antibody against CD109 (anti-CD109) were designed for functional or treatment studies in RA FLSs and CIA. RESULTS: CD109 was found to be abundantly expressed in the synovial tissues from RA patients and CIA mice. CD109 expression in RA FLSs was upregulated by inflammatory stimuli, such as interleukin-1β and tumour necrosis factor-α. Silencing of CD109 or anti-CD109 treatment reduced proinflammatory factor production, cell migration, invasion, chemoattractive potential and osteoclast differentiation, thereby reducing the deleterious inflammatory response of RA FLSs in vitro. Mice lacking CD109 were protected against arthritis in the CIA model. Anti-CD109 treatment prevented the onset and ameliorated the severity of CIA lesions. CONCLUSION: Our study uncovers an antiarthritic role for CD109 and suggests that CD109 inhibition might serve as a promising novel therapeutic strategy for RA.
引用
- Song G, Feng T, Zhao R, et al. CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2019. PMID: 31455659. doi:10.1136/annrheumdis-2019-215473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。